217.1 Non-thrombogenic costimulation blockade in preclinical cardiac xenotransplantation using a combination of anti-CD40L PAS Fab and chimeric anti-CD40 antibody
Jan-Michael Abicht, Germany
217.2 Comparative clinical analysis in pig-to-rhesus corneal xenotransplantation depending on various immunosuppressants
Ms. Seung Hyeun Lee, Korea
217.3 Invasive versus Echocardiographic Hemodynamics in the First Genetically Modified Porcine to Human Xenotransplant
Cullen Soares, United States
217.5 Clinical subjects may suitable for renal xenotransplantation because of lower anti-pig antibodies
Mr. Yifan Yu, People's Republic of China
217.6 Beneficial effects of transgenic expression of human CD200 on top of quadruple-knockout/double-knockin (CD46/thrombomodulin) pigs on kidney xenograft survival in nonhuman primates